Johnson & Johnson Earnings Beat Boosted by Hepatitis Drug - Presented by: The Aol. On Network

Shares of Johnson & Johnson are in focus on Tuesday after the company posted second quarter results which were better than what Wall Street was expecting. Johnson & Johnson says sales around the world were strong. Excluding one time charges, J&J earned $1.66 a share, that's more than 10 cents better than expectations. Revenue for the quarter was $19.5 billion, slightly better than expectations and a 9 percent increase compared to the same period a year ago.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 114.48 3.96 ▼ 3.34%
S $ 3.545 0.21 ▲ 6.14%
BAX $ 40.835 1.33 ▲ 3.35%
BAC $ 17.86 0.09 ▲ 0.51%
FTR $ 5.20 0.05 ▲ 0.97%
BXLT $ 37.545 4.40 ▲ 13.26%
MSFT $ 47.43 0.62 ▲ 1.32%
PBR $ 6.53 0.18 ▲ 2.83%

As of 8/4/2015, 11:12 AM